These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15770814)

  • 21. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Helicobacter pylori infection as additional risk factor of the development of NSAID-gastropatia effects at the patients with osteoarthritis].
    Maev IV; Samsonov AA; Lezhneva IuA; Andreev NG; Salova LM
    Eksp Klin Gastroenterol; 2009; (5):69-72. PubMed ID: 20201308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori and non-malignant diseases.
    Shirin H; Leja M; Niv Y
    Helicobacter; 2008 Oct; 13 Suppl 1():23-7. PubMed ID: 18783518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of gastroesophageal reflux: should Helicobacter pylori infection be taken into account?].
    De Korwin JD
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S121-9. PubMed ID: 10078440
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
    Kiltz U; Zochling J; Schmidt WE; Braun J
    Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric ulcer after laparoscopic fundoplication for gastroesophageal reflux disease: significance of the eradication of Helicobacter pylori.
    Omura N; Kashiwagi H; Yano F; Tsuboi K; Ishibashi Y; Kawasaki N; Suzuki Y; Matsumoto A; Mitsumori N; Urashima M; Yanaga K
    Surg Laparosc Endosc Percutan Tech; 2007 Jun; 17(3):193-6. PubMed ID: 17581465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
    Horvat D; Vcev A; Soldo I; Timarac J; Dmitrović B; Misević T; Ivezić Z; Kraljik N
    Coll Antropol; 2005 Jun; 29(1):139-42. PubMed ID: 16117312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding NSAID-PPI-COX-2 interrelationships.
    Singh G
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():21-4. PubMed ID: 15190384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the treatment of patients with Helicobacter pylori.
    Zullo A; Vaira D
    Am Fam Physician; 2007 Sep; 76(5):633. PubMed ID: 17894129
    [No Abstract]   [Full Text] [Related]  

  • 35. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of use of proton pump inhibitors in Greece.
    Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
    Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Nakamura M; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Int J Mol Med; 2007 Sep; 20(3):373-8. PubMed ID: 17671743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment and prophylaxis of alimentary tract lesions caused by non-steroid anti-inflammatory drugs].
    Gil J; Wojtuń S
    Pol Merkur Lekarski; 2009 May; 26(155):353-7. PubMed ID: 19606672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 40. [SBU report on abdominal pain. Dyspepsia is an umbrella term for one of the most common public disease].
    Lakartidningen; 2000 Dec; 97(50):5904-9. PubMed ID: 11188532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.